ESC 365 - Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers

ESC Premium Access

Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers

Session: Poster Session 5 - Heart values

Topic: Pharmacotherapy

Speaker: Professor M. Soares Sturzeneker (Ponta Grossa, BR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Mario Claudio Soares Sturzeneker

Ponta Grossa State University, Ponta Grossa (Brazil)

0 follower

11 more presentations in this session

Changes of TRPV4-BKCa complex in rat mesenteric artery in aging and hypertension

Speaker: Professor Y. Yang (Luzhou, CN)

NI956/QGC006, a potent orally active, brain-penetrating aminopeptidase A inhibitor prodrug for treating hypertension.

Speaker: Doctor M. Keck (Paris, FR)

Transforming growth factor-beta and arrhythmias in mitral valve prolapse patients

Speaker: Professor E. Malev (Saint Petersburg, RU)

Notch-dependent endothelial dysfunction in patients with aortic valve calcification

Speaker: Doctor A. Kostina (Saint Petersburg, RU)

The number of lipoprotein(a) kringle IV-type 2 repeats is associated with the osteogenic profile of aortic valvular interstitial cells induced by plasma from patients with calcific aortic stenosis

Speaker: Doctor D. Arangalage (Lausanne, CH)

Access the full session

Poster Session 5 - Heart values

Speakers: Professor M. Soares Sturzeneker, Professor Y. Yang, Doctor M. Keck, Professor E. Malev, Doctor A. Kostina...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources